Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with age-related macular degeneration: independent statistical evaluations of data from the Age-Related Eye Disease Study

摘要

PURPOSERecent years have seen considerable controversy as to whether genotyping should be part of standard care for patients with age-related macular degeneration (AMD) being considered for treatment with antioxidants and zinc. We aimed to determine whether genotype predicts response to supplements in AMD.